Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Non Operating Income came in at -$20.7 million in Q4 2025, down 75.11% year-on-year from -$83.1 million in Q4 2024, and down 96.23% quarter-over-quarter from -$10.5 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Non Operating Income history runs 16 years deep, the most recent figure standing at -$20.7 million for Q4 2025.
- On a quarterly basis, Non Operating Income fell 75.11% year-over-year to -$20.7 million in Q4 2025; TTM through Dec 2025 was -$55.7 million, a 5.13% decrease from a year earlier, with the FY2025 full-year figure at -$52.6 million, up 20.81% from the prior year.
- Non Operating Income slipped to -$20.7 million in Q4 2025 per PBH's latest filing, from -$10.5 million in the prior quarter.
- Across five years, Non Operating Income topped out at -$10.0 million in Q2 2025 and bottomed at -$30.6 million in Q1 2021.
- The 5-year median for Non Operating Income is -$16.5 million (2022), against an average of -$16.5 million.
- Across the five-year window, Non Operating Income soared 46.15% in 2022 and sank 75.11% in 2025, its largest moves.
- Year by year, Non Operating Income stood at -$17.1 million in 2021, then decreased by 11.5% to -$19.1 million in 2022, then grew by 9.49% to -$17.3 million in 2023, then jumped by 31.58% to -$11.8 million in 2024, then sank by 75.11% to -$20.7 million in 2025.
- Per Business Quant, the three latest PBH Non Operating Income figures stand at -$20.7 million (Q4 2025), -$10.5 million (Q3 2025), and -$10.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | -20.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.68 Mn |
| Sep 30, 2025 | -10.54 Mn |
| Jun 30, 2025 | -9.98 Mn |
| Mar 31, 2025 | -14.47 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | -14.83 Mn |
| Dec 31, 2023 | -17.26 Mn |
| Sep 30, 2023 | -17.84 Mn |
| Jun 30, 2023 | -16.48 Mn |
| Mar 31, 2023 | -18.53 Mn |
| Dec 31, 2022 | -19.07 Mn |
| Sep 30, 2022 | -17.79 Mn |
| Jun 30, 2022 | -16.12 Mn |
| Mar 31, 2022 | -16.46 Mn |
| Dec 31, 2021 | -17.10 Mn |
| Sep 30, 2021 | -18.93 Mn |
| Jun 30, 2021 | -14.97 Mn |
| Mar 31, 2021 | -30.56 Mn |